Replit’s new feature generates iOS apps from text prompts, integrates monetization, and streamlines App Store publishing - ...
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Find out the direct holders, institutional holders and mutual fund holders for Replimune Group, Inc. (REPL).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback